Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function
Zoe Arvanitakis, Hoau‐Yan Wang, Ana W. Capuano, et al.
Annals of Neurology (2020) Vol. 88, Iss. 3, pp. 513-525
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Intranasal Insulin for Alzheimer’s Disease
Manfred Hallschmid
CNS Drugs (2021) Vol. 35, Iss. 1, pp. 21-37
Open Access | Times Cited: 112
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 84
Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular docking strategy: Acetyl tributyl citrate as an example
Shujun Huang
The Science of The Total Environment (2023) Vol. 905, pp. 167904-167904
Closed Access | Times Cited: 63
Automated detection of Alzheimer’s disease: a multi-modal approach with 3D MRI and amyloid PET
Giovanna Castellano, Andrea Esposito, Eufemia Lella, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Exploring the mechanism of PPCPs on human metabolic diseases based on network toxicology and molecular docking
Ming Cheng, Mengnan Li, Yunmei Zhang, et al.
Environment International (2025) Vol. 196, pp. 109324-109324
Open Access | Times Cited: 2
Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 110
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Çağlar Coşarderelioğlu, Lolita S. Nidadavolu, Claudene J. George, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 109
Intranasal insulin
Manfred Hallschmid
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 4
Open Access | Times Cited: 72
Brain Metabolic Alterations in Alzheimer’s Disease
Carlos G. Ardanaz, Marı́a J. Ramı́rez, Maite Solas
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3785-3785
Open Access | Times Cited: 67
The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer’s Disease Mechanism Determined by a Network Pharmacology Approach
Peng Zeng, Xiaoming Wang, Chao‐Yuan Ye, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3612-3612
Open Access | Times Cited: 65
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 59
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 58
Cerebrovascular insulin receptors are defective in Alzheimer’s disease
Manon Leclerc, Philippe Bourassa, Cyntia Tremblay, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 75-90
Open Access | Times Cited: 56
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
Jordi Olloquequi, Amanda Cano, Elena Sánchez‐López, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113709-113709
Open Access | Times Cited: 39
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, et al.
Aging and Disease (2023)
Open Access | Times Cited: 35
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 35
Insulin resistance, cognition, and Alzheimer disease
Anne B. Kim, Zoe Arvanitakis
Obesity (2023) Vol. 31, Iss. 6, pp. 1486-1498
Closed Access | Times Cited: 23
High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?
Josue Valentin‐Escalera, Manon Leclerc, Frédéric Calon
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 977-1005
Open Access | Times Cited: 13
Enzyme-responsive, multi-lock optical probes for molecular imaging and disease theranostics
Penghui Cheng, Kanyi Pu
Chemical Society Reviews (2024)
Closed Access | Times Cited: 11
Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia
Roshni Biswas, Ana W. Capuano, Rupal I. Mehta, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 1
Open Access | Times Cited: 1
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation
Qin Zhang, Kangyu Jin, Bing Chen, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 31
Developing a Two-Photon “AND” Logic Probe and Its Application in Alzheimer’s Disease Differentiation
Jingxuan Guo, Jia Sun, Donghui Liu, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 46, pp. 16868-16876
Closed Access | Times Cited: 19
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Saghar Rabiei Poor, Miren Ettcheto, Amanda Cano, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 890-890
Open Access | Times Cited: 33
A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease
Xinyan Wu, Xiaomei Zheng, Huaqiao Tang, et al.
Medicine (2022) Vol. 101, Iss. 34, pp. e30194-e30194
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top